These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7426749)

  • 1. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions.
    Chediak J; Ashenhurst JB; Garlick I; Desser RK
    Blood; 1980 Nov; 56(5):835-41. PubMed ID: 7426749
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of factor V inhibitor.
    Chong LL; Wong YC
    Am J Hematol; 1985 Aug; 19(4):395-9. PubMed ID: 4025315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.
    Kadohira Y; Yamada S; Hayashi T; Morishita E; Asakura H; Ichinose A
    Int J Hematol; 2018 Aug; 108(2):145-150. PubMed ID: 29611057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood transfusion as substitution therapy in factor V- and factor VII deficiency].
    THIES HA; BOECKER D
    Munch Med Wochenschr; 1955 Dec; 97(51):1717-8. PubMed ID: 13288517
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.
    Li F; Shu K; Liu J; Shen C; Wang X; Zhang Z; Jiang M
    Acta Haematol; 2019; 141(3):148-150. PubMed ID: 30783058
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation and bleeding disorders: review and update.
    Triplett DA
    Clin Chem; 2000 Aug; 46(8 Pt 2):1260-9. PubMed ID: 10926920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis.
    George S; Nagabhushana MS; Cyran EM
    Am J Hematol; 1995 May; 49(1):98-100. PubMed ID: 7741151
    [No Abstract]   [Full Text] [Related]  

  • 8. CONGENITAL DEFICIENCY OF FACTOR VII (HYPOCONVERTINEMIA). CRITICAL REVIEW OF LITERATURE AND REPORT OF THREE CASES, WITH EXTENSIVE PEDIGREE STUDY AND EFFECT OF TRANSFUSIONS.
    OWEN CA; AMUNDSEN MA; THOMPSON JH; SPITTELL JA; BOWIE EJ; STILWELL GG; HEWLETT JS; MILLS SD; SAUER WG; GAGE RP
    Am J Med; 1964 Jul; 37():71-91. PubMed ID: 14181151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anesthetic management of a patient with acquired factor V inhibitor].
    Nakamura T; Otsuji M; Kurita A; Yamada K; Tsubokawa T; Yamamoto K
    Masui; 2010 Nov; 59(11):1423-7. PubMed ID: 21077315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding due to an acquired inhibitor of platelet associated factor V.
    Grigg AP; Dauer R; Thurlow PJ
    Aust N Z J Med; 1989 Aug; 19(4):310-4. PubMed ID: 2675811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE CORRECTION OF PROLONGED BLEEDING TIMES IN TWO BROTHERS BY PLATELET TRANSFUSIONS DESPITE NORMAL IN VITRO PLATELET TESTS.
    WHITE JG; YUNIS E; COLLIANDER M; KRIVIT W
    Pediatrics; 1964 Apr; 33():579-84. PubMed ID: 14166539
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency.
    Mouton C; Leroux L; Bonnet G; Seguy B; Lafargue A; Baulier G; Castet S; Fiore M
    Ann Hematol; 2019 Aug; 98(8):1991-1992. PubMed ID: 30830247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acquired factor V inhibitor].
    Yamada S; Asakura H
    Rinsho Ketsueki; 2020; 61(7):791-798. PubMed ID: 32759567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 15. High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.
    Nakata K; Ueda S; Matsunaga H; Mima F; Ueda H; Yoshioka A; Kaneko S; Maruo K; Morris S; Yonemoto S; Hayashi D; Fujii N; Narahara H; Inui Y; Kawata S
    Intern Med; 2018 Feb; 57(3):393-397. PubMed ID: 29093398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of an acquired Factor V inhibitor to activated Factor IX concentrate.
    Vickars LM; Coupland RW; Naiman SC
    Transfusion; 1985; 25(1):51-3. PubMed ID: 3871542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hemorrhagic complications of open-heart surgery.
    Leichtman DA; Friedman BA
    CRC Crit Rev Clin Lab Sci; 1977 Apr; 7(3):239-54. PubMed ID: 324709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
    Borucki K; Töpfer G; Hartung KJ; Lutze G
    Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation in a patient with an acquired high-titre factor V inhibitor.
    Schmidt DE; Steinhagen F; Schnabel C; Spath B; Holstein K; Fiedler W; Bokemeyer C; Renné T; Langer F
    Blood Coagul Fibrinolysis; 2015 Jan; 26(1):81-7. PubMed ID: 25158984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass.
    Essell JH; Martin TJ; Salinas J; Thompson JM; Smith VC
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):410-5. PubMed ID: 8400095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.